0.2980	1.9545	ORPHANET:1918	FETAL MINOXIDIL SYNDROME		
0.8009	2.4700	OMIM:150699	#150699 LEIOMYOMA, UTERINE; UL	HMGA2	8091
0.8009	2.4700	OMIM:192000	UTERINE ANOMALIES		
0.8009	2.4700	OMIM:608089	ENDOMETRIAL CANCER	MSH6, MLH3, PTEN, CDH1	2956, 27030, 5728, 999
0.8009	2.3493	OMIM:107100	ANORECTAL ANOMALIES		
0.8009	2.3078	OMIM:136500	FOCAL FACIAL DERMAL DYSPLASIA		
0.8009	2.2872	OMIM:139500	HAIRY EARS		
0.8009	2.2872	OMIM:128710	EAR PITS, POSTERIOR HELICAL		
0.8009	2.2712	OMIM:612567	#612567 INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25;;INFLAMMATORY BOWEL DISEASE, EARLY-ONSET, AUTOSOMAL RECESSIVE	IL10RB	3588
0.8009	2.2487	OMIM:107480	TOWNES-BROCKS SYNDROME	SALL1	6299
0.8009	2.1704	OMIM:300758	#300758 HYPOSPADIAS 2, X-LINKED; HYSP2	MAMLD1	10046
0.8009	2.1704	OMIM:146450	%146450 HYPOSPADIAS 3, AUTOSOMAL; HYSP3		
0.8009	2.1704	OMIM:235600	HERMAPHRODITISM, TRUE		
0.8009	2.1704	OMIM:300633	#300633 HYPOSPADIAS 1, X-LINKED; HYSP1	AR	367
0.8009	2.1348	OMIM:614350	#614350 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5	MSH6	2956
0.8009	2.1348	OMIM:612591	#612591 COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10;;COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 19Q		
0.8009	2.0905	OMIM:612551	#612551 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4;;END-STAGE RENAL DISEASE, NONDIABETIC, SUSCEPTIBILITY TO, INCLUDED	APOL1	8542
0.8009	2.0883	OMIM:234000	FACTOR XII DEFICIENCY	F12	2161
0.8009	2.0883	OMIM:228960	FLAUJEAC FACTOR DEFICIENCY		
0.8009	2.0883	OMIM:612423	#612423 PREKALLIKREIN DEFICIENCY;;PKK DEFICIENCY;;FLETCHER FACTOR DEFICIENCY	KLKB1	3818
